Latest Pneumococcal conjugate vaccine Stories
NEW YORK, Aug.
BEIJING, Aug. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.
PHILADELPHIA, July 19 /PRNewswire-USNewswire/ -- A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.
James E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis ROCKVILLE, Md., July 1 /PRNewswire-USNewswire/ -- The Aeras Global TB Vaccine Foundation today announced that James E. Connolly has been named President and Chief Executive Officer.
PHILADELPHIA, May 14 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined that U.S. healthcare practitioners can resume the use of RotarixÂ® (Rotavirus Vaccine, Live, Oral), effective immediately.
New study reinforces urgent need for life-saving vaccines in Africa.
BEIJING, April 6 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Two of the largest pharmaceutical companies in the world have agreed to a 10-year commitment to supply new pneumonia vaccines to developing nations across the globe.
LONDON, March 23 /PRNewswire-FirstCall/ -- GSK (NYSE: GSK) has become one of the first manufacturers to sign a unique agreement with the GAVI Alliance (GAVI) that has the potential to save millions of children from dying in the world's poorest countries.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.